Immuneering Corporation (IMRX) is expected to be added to the Nasdaq Biotechnology Index (NBI). Immuneering’s addition will become effective prior to market open on Monday, December 22, 2025.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMRX: